← Evidence map

ArticleJournal of managed care & specialty pharmacy2021

Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.

Gregory F Guzauskas et al.PubMed ↗Full text ↗

No numbers read from the abstract.

10 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33769850